Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03473275
Other study ID # 2018-00105
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 16, 2018
Est. completion date August 12, 2022

Study information

Verified date February 2023
Source Centre Hospitalier Universitaire Vaudois
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study will explore the brainstem activity in response to stress in hypertensive patients and normotensive subjects. In addition, it will evaluate if the response in hypertensive patients can be modulated by blocking the afferent signalling of sympathetic nervous system from the kidney to the brain achieved by renal denervation. The investigators hypothesize that the change in BOLD signal intensity in response to stress is higher in hypertensive patients than in normotensive subjects and that in patients responsive to renal denervation the change in BOLD signal intensity in response to stress is decreased compared to non-responders or to non-denervated resistant hypertensive patients.


Description:

In hypertension, the overactivity of the sympathetic nervous system (SNS) has been found to be implicated in its initiation, maintenance and adverse consequences. The SNS is composed of an afferent and efferent arm, which brings sensory information to the brain (e.g. brainstem and hypothalamus) and transmits sympathetic outflow from the brain to the peripheral organs, respectively. Selective removal of the afferent renal component of the SNS can modulate central sympathetic outflow to the kidney, heart and vasculature in animals. The specific contribution of afferent nerve signalling in hypertension and in the potential antihypertensive effect of renal denervation has not been studied in humans.


Recruitment information / eligibility

Status Completed
Enrollment 84
Est. completion date August 12, 2022
Est. primary completion date August 12, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - signed informed consent - capable of discernment Exclusion Criteria: - having contra-indications for MRI (claustrophobia, cardiac pacemaker or other metallic or mechanical implant or device, etc.) - pregnant women - lower limb sensitive neuropathy - Blood pressure >180/110 mmHg during washout period (for hypertensive patients) - Intolerance to Sonovue®(ultrasound contrast agent) - Acute or chronic disease other than hypertension that influences renal function - taking medication/drugs, except of calcium channel blockers for resistant hypertensive patients

Study Design


Intervention

Diagnostic Test:
Cold Pressor test
Both feet in icy waterbath alternated with body temperature water
PinPrick test
Pricking both feet with a needle using gravity (without penetrating) alternated with cotton swap

Locations

Country Name City State
Switzerland CHUV, nephrology service Lausanne Vaud

Sponsors (2)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire Vaudois Ecole Polytechnique Fédérale de Lausanne

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in brain BOLD signal intensity Changes in the brain BOLD fMRI signal of the brainstem in response to a cold pressor test 1.5 hours
Secondary Functional connectivity (resting state and effective connectivity) Activation patterns in spatially separated brain regions tending to have synchronous activity in resting state and activation pattern changes during a cold pressor test 1.5 hours
Secondary Structural connectivity Map of anatomical (neural) connections within the brain in normotensive subjects and hypertensive patients 30 minutes
Secondary Correlation between brain BOLD fMRI and renal ultrasound Correlation between changes in brain BOLD signal and renal (contrast-enhanced) ultrasound endpoints 2 hours
See also
  Status Clinical Trial Phase
Recruiting NCT05546931 - Mobile Health Program for Rural Hypertension N/A
Completed NCT05086549 - An Observation Study to Evaluate the Renoprotective Effect of Fimasartan in Patients With DKD and Proteinuria
Recruiting NCT05086523 - Cardiac Neuromodulation Therapy (CNT) "Washout" Sub-Study Phase 1/Phase 2
Active, not recruiting NCT03503773 - The TARGET BP OFF-MED Trial Phase 2
Not yet recruiting NCT04082091 - Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
Recruiting NCT06019598 - Licorice and Home Blood Pressure, Additional Study N/A
Completed NCT04495231 - Sympathetic Activity and Cardiometabolic Complications
Completed NCT04119999 - A Cardiosleep Research Program on Obstructive Sleep Apnea, Blood Pressure Control and Maladaptive Myocardial Remodeling N/A
Recruiting NCT04505618 - Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease N/A
Recruiting NCT04863508 - Wearable Blood Pressure Devices to Identify Masked Uncontrolled Hypertension.
Completed NCT05185297 - Recreational Futsal for Controlled Hypertension N/A
Completed NCT03855605 - Diagnosis of Hypertension by Home Blood Pressure Monitoring
Completed NCT03901183 - Plant-based Nutrition for Patients With Cardiovascular Risk Factors N/A
Recruiting NCT06348576 - Phase III Study to Evaluate the Efficacy and Safety of AD-209 Phase 3
Recruiting NCT03206814 - Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System N/A
Recruiting NCT06343246 - Functional Inspiratory Muscle Training in Patients Diagnosed With Hypertension N/A
Completed NCT06359873 - Left Atrial Enlargement: A Crucial Indicator for Identifying Atrial Fibrillation in Patients With Hypertension
Recruiting NCT04565548 - Hypertension Treatment Adherence Improving Trial N/A
Recruiting NCT06205628 - Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension Phase 1
Recruiting NCT04613193 - Blood Pressure Reduction in Patients With Asymptomatic Aortic VALVE Stenosis N/A